Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Rezolute, Inc. (RZLT) Financial Statements

Free cash flow over the same period: -$64.6M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RZLTRezolute, Inc.Follow RZLT — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
372.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26. Results for the next quarter were released 24 Sep; these figures move once the 10-Q is filed.

LineFY2012
Jun 12
FY2013
Jun 13
FY2014
Jun 14
FY2015
Jun 15
FY2016
Jun 16
FY2017
Jun 17
FY2018
Jun 18
FY2019
Jun 19
FY2020
Jun 20
FY2021
Jun 21
FY2022
Jun 22
FY2023
Jun 23
FY2024
Jun 24
FY2025
Jun 25
FY2026
Jun 26
TTM
Jun 26
Trend
Research & development0.00.00.04.79.412.117.319.114.515.032.543.855.761.553.853.8
Operating income—-6.1-5.2-10.7-15.0-20.3-28.7-25.9-20.5-22.9-41.8-56.0-70.4-79.9-83.0-83.0
Pre-tax income—-6.7-9.7-11.4-14.9-20.3-29.9-30.4-20.3-20.9-41.1-51.8-68.5-74.4-77.6-77.6
Income tax—0.00.00.00.00.00.00.00.00.00.00.00.00.00.0—
Net income-0.0-6.7-9.7-11.4-14.9-20.3-29.9-32.7-20.3-20.9-41.1-51.8-68.5-74.4-77.6-77.6
Diluted EPS ($)-0.01-1.08-1.04-0.54-0.84-0.57-0.54-18.41-3.54-2.72-2.32-1.01-1.33-0.98-0.75-0.76
Diluted shares (mn)——9.4——————7.719.551.251.576.0103.9—

USD millions · SEC XBRL

Rezolute, Inc. — questions

What is Rezolute, Inc.'s net income?
-$77.6M over the twelve months to 2026-06-30.
What is Rezolute, Inc.'s free cash flow?
-$64.6M over the twelve months to 2026-06-30.
What are Rezolute, Inc.'s diluted earnings per share?
$-0.76 over the twelve months to 2026-06-30.

Every figure on this page comes from Rezolute, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.